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Abstract
Background: The use of gene expression profiling for the classification of human cancer tumors has been widely 
investigated. Previous studies were successful in distinguishing several tumor types in binary problems. As there are 
over a hundred types of cancers, and potentially even more subtypes, it is essential to develop multi-category 
methodologies for molecular classification for any meaningful practical application.
Results: A jackknife-based supervised learning method called paired-samples test algorithm (PST), coupled with a 
binary classification model based on linear regression, was proposed and applied to two well known and challenging 
datasets consisting of 14 (GCM dataset) and 9 (NC160 dataset) tumor types. The results showed that the proposed 
method improved the prediction accuracy of the test samples for the GCM dataset, especially when t-statistic was used 
in the primary feature selection. For the NCI60 dataset, the application of PST improved prediction accuracy when the 
numbers of used genes were relatively small (100 or 200). These improvements made the binary classification method 
more robust to the gene selection mechanism and the size of genes to be used. The overall prediction accuracies were 
competitive in comparison to the most accurate results obtained by several previous studies on the same datasets and 
with other methods. Furthermore, the relative confidence R(T) provided a unique insight into the sources of the 
uncertainty shown in the statistical classification and the potential variants within the same tumor type.
Conclusion: We proposed a novel bagging method for the classification and uncertainty assessment of multi-
category tumor samples using gene expression information. The strengths were demonstrated in the application to 
two bench datasets.
Background
The use of gene expression profiling for the classification
of human cancers has been widely investigated. Previous
works were successful in predicting tumor types in the
context of binary problems. Many algorithms for feature
extraction and sample classification have been proposed
[1-6]. More recently, a method for addressing the poten-
tial mislabeling in the training set was proposed for
binary classification of cancer samples [7]. As there are
over a hundred types of cancers, and potentially even
more subtypes [8], it is essential to develop multi-cate-
gory methodologies for molecular classification for any
practical application [9].
Multi-category prediction can be achieved using binary
classification algorithms via the one-versus-one (OVO)
and/or one-versus-rest (OVR) partition of the training
data set. However, in a cancer type prediction, multi-cat-
egory problems proved to be more challenging than sim-
ple binary problems, and the reported results were less
than satisfactory [3,10]. On one hand, when the available
resource is limited and the sample size of a given category
(class) is small, classifiers based on the OVR partition of
the data set potentially suffer from severe over-fitting,
leading to low predictive ability and robustness. Further-
more, the substantial noise introduced by implementing
the numerous classifiers under an OVO scheme and the
asymmetric training sets caused by OVR partitioning of
the data will inevitably weaken the classification system.
On the other hand, the effects of biological and technical
noise together with the genetic heterogeneity of samples
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within a clinically defined tumor class decrease the pre-
dictive power in a multiple setting [11].
In disease diagnostic, a measurement of confidence or
uncertainty reported with the type determination is
always desirable [6]. However, some well-established sta-
tistical criteria (such as classification probability) often
become less credible and of little biological meaning for
highly heterogeneous cancer types, especially in the con-
text of multiple cancer types. A potential reason is that
the winning classifier used to discriminate one cancer
type from others could be weak or unstable due to limited
training samples. Although this phenomenon was alluded
to in previous studies [11], it has not received appropriate
attention. Figure 1 presents a graphical illustration of the
problem. Using an OVR binary classifier, all samples of a
homogeneous cancer type (A) were classified correctly
and with high confidence. All other cancer type samples
in the group have probabilities of being cancer type A
close to zero (Figure 1a). However, the situation was very
different when a heterogeneous cancer class (B) was con-
sidered. In fact, some samples of cancer B type had classi-
fication probability lower than 0.5 (Figure 1b). Such low
classification probability could lead to misdiagnosis if a
hard classification rule is applied. It is possible that such
low probability is due to the weakness of the classifier
that is established with a highly heterogeneous training
set.
The jackknife is a well known, non-parametric method
often used for estimating the sampling distribution of a
statistic. Given a sample dataset and a desired statistic
(e.g., the mean), the jackknife works by computing the
desired statistic with an element (or a group of elements)
removed from the equation. The process is repeated for
each element in the dataset. The application in cancer
classification with gene expression profiling has been
reported in the context of binary problems [12]. In that
study, the individual maximum difference subsets
(MDSSs) of genes identified from a set of jackknife sub-
sets of samples were aggregated to generate the "overall
MDSS" in order to return the expected classification. In
other words, jackknife was used for feature selection
rather than for training multiple sub-classifiers.
In this study, a new learning method called paired-sam-
ples test algorithm (PST), which is based on the jackknife
method, was used to classify multiple tumor types using
gene expression data. The proposed method is designed
for solving multi-category problems under an OVR
scheme with a very limited training data set, and it is sim-
ilar to the bootstrap aggregating (bagging) procedure,
which proved to be helpful in improving weak classifiers
[13,14]. In order to get a relative measurement of uncer-
tainty in the prediction of a sample category (class), the
training sample being removed (validation sample) each
time was predicted together with the training samples.
The procedure was implemented in a parsimonious way,
making its integration with a computationally intensive
algorithm, such as the stochastic, regulation-based binary
regression [6], feasible. The performance of the proposed
method was evaluated under several scenarios of gene
selection criteria using two well known and challenging
datasets: the GCM and NCI60 datasets containing 14 and
9 cancer tumor types, respectively.
Results and Discussion
Determination of the optimum number of genes (fea-
tures) to be used by the classification algorithm is usually
a difficult task that depends on several factors, including
the classification algorithms and the complexity of the
data set. For the used binary regression algorithm, previ-
ous studies have shown that a feature set of one to two
hundred top genes is adequate for a simple two category
problem [6,7]. In this study , the size of the feature set
used was 200, 300, 500 or 1000 genes for the GCM data-
set and 100, 200, 300 or 5000 genes for the NCI60 data-
set.
GCM data
The prediction accuracy of the 54 validation samples,
using different gene selection procedures, is summarized
in Figure 2. The results showed that fold change and
penalized t-statistic based methods for feature selection
outperformed the t-statistic-based procedure. In most
cases, the application of PST improved the prediction
Figure 1 Classification probability of a) low heterogeneity cancer 
type A and b) high heterogeneous cancer B using one-versus-rest 
(OVR) classifiers.
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accuracy or maintained the high accuracies that had been
obtained prior to its application, except in the scenario of
1000 genes and penalized t-statistic. The largest improve-
ment occurred when 200 genes were considered using
different feature selection criteria, resulting in an
increase in accuracy ranging from 9.3% to 16.7%. The
combination of 500 genes, fold change-based feature
selection and PST had the highest prediction accuracy of
83.4%. Additionally, almost 50% of the 16.6% incorrectly
classified samples had their true tumor type predicted as
the second possible classification in this scenario.
It should be noted that while the largest improvements
were seemingly coming from the weaker gene selection
mechanisms, the application of PST made the binary
regression algorithm more robust in relation to the gene
selection methods and the size of the gene set to be used.
These prediction results are, in general, better than
those obtained by several previous studies using the same
data set (Table 1). Using a recursive feature elimination
procedure and a support vector machine (SVM) classifi-
cation algorithm, Ramaswamy et al. (2001) obtained their
best result with 42 tumors correctly predicted among the
54 test samples, corresponding to an accuracy of 78%
[11]. Using a feature selection algorithm based on the
overlaps of gene expression values between different
classes in conjunction with the Covering Classification
Algorithm (CCA), a modification of the k-NN method,
Bagirov et al. (2003) achieved a prediction accuracy of
around 80% [15]. Based on the concept of gene interac-
tion, Antonov et al (2004) proposed a Maximal Margin
Linear Programming (MAMA) procedure that combines
linear programming (LP) and SVM [16]. Using MAMA,
only eight test samples were misclassified. Although
Figure 2 Improvement in prediction accuracy when the proposed jackknife-like method using the independent test for GCM dataset.
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slightly superior to our method (8 vs. 9 misclassified sam-
ples) in the overall accuracy, the lack of information
about confusion profiles of the prediction and the sec-
ondary classification of non-correctly predicted samples
make the direct comparison between both methods diffi-
cult. Recently, Sheng and Tan (2006) reported a predic-
tion accuracy of around 83% by using error correcting out
codes (ECOC), SVM and a recursive feature elimination
procedure [17]. The output coding based approach is
very costly in implementation and the result was highly
sensitive to the decoding functions and the length of the
random code.
It is possible that the superiority of the proposed
method over SVM and other learning algorithms could
be related to the difference in gene selection methods
used in this study and by Ramaswamy et al (2001) and
Bagirov et al (2003) [11,15]. However, our preliminary
work as well as readily available information [10,18] dem-
onstrated that SVM outperformed k-NN, NN (neural
network), PNN (probabilistic neural work) and the deci-
sion tree in general does not support such a claim. In fact,
the highest accuracies obtained using SVM occurred
when 200-1000 genes were selected based on FC, t-statis-
tics, penalized t-statistics and non-parametric ANOVA,
ranging from 72.2% to 75.9%. These were well below the
results obtained using our approach.
As indicated in Table 1, it seems that some tumor types
are easily predicted. For example, LY, UT, ME and CSN
tumors had 100% prediction accuracy using all three
methods. Meanwhile, other types, such as BR, had a high
misclassification rate ranging from 50 to 75%, indicating
potential excess heterogeneity. Additionally, the profile of
misclassified samples was very different between the four
studies. In fact, among the four BR tumors, two were mis-
classified as OV and PA in Ramaswamy et al (2001) [11],
three were misclassified as LU, LU and BL in Bagirov et al
(2003) [15], and three were misclassified as LE, PA, and
UT in the current study.
To further validate the results behind the use of the
independent 54 test samples, a four-fold cross validation
was conducted for the 144 training samples. The results
of this validation are presented in Figure 3. In most sce-
narios, the prediction accuracy was improved when the
proposed Jackknife method was used. The highest value
was 82.6%, which was achieved from several combina-
tions of the gene selection method and gene number,
including the case of FC-based gene selection and 500
genes. This accuracy value was similar to the best perfor-
mance of 83.4% obtained using the independent 54 test
samples, and it is 5.6% higher than the accuracy obtained
by Ramaswamy et al (2001) [11].The NP-ANOVA feature
selection performed marginally better in the cross valida-
Table 1: Comparison between the incorrectly classified samples obtained using the proposed method and previous 
studies using the same data set.
Misclassified samplesa
Tumor Type Test samples Ramaswamy (2001) Bagirov (2003) Current Study
BR 4 2(OV, PA) 3(LU, LU, BL) 3(LE, PA, UT)
PR 6 2(OV, UT) 2(BR, UT)
LU 4 2(BL, ML) 0 1(BL)
CO 4 0 1(UT) 1(CSN)
L Y 6000
BL 3 1(ML) 2(UT, PA) 0
ML 2 1(BL) 0 1(RE)
U T 2000
LE 6 1(PR) 0 0
RE 3 0 2(BR, UT) 0
PA 3 1(BR) 1(CO) 0
OV 4 2(ML, PA) 0 2(BL, CL)
M E 3001 ( R E )
C S N 4000
Total 54 12 11 0
9
a In parenthesis are the assigned tumor types for the misclassified samples.Zhang et al. BMC Genomics 2010, 11:273
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tion than in the independent test with the highest predic-
tion accuracy of 82.0%.
PPP rediction uncertainty
Uncertainty of the 45 correctly classified test samples
from the best result is graphically presented in Figure 4.
Among these 45 samples, eight tumors (1 ML, 5 LE, 3
CNS) had high F(T) (>.75) and nearly 3/4 of the tumors
had their prediction confidence < 0.5. For the classifica-
tion algorithm used in this study, F(T) was defined as the
aggregate probability that the test sample T belongs to the
assigned tumor type. In this context, considering F(T)
alone makes the current prediction results seem unex-
pected. However, when taking R(T) values into account,
confidence measurement, or F(T), appears to be in better
agreement with the results of this study. Of those samples
with lower prediction confidence, the majority had their
R(T) between -0.15 and 0.15, suggesting that their lower
prediction confidences were mainly due to the potential
weakness of the classifiers and/or some moderate hetero-
geneity. In addition, the profile of the four metastatic
prostate (PR) samples was interesting. Although they
were predicted with 100% accuracy, their relative confi-
dences were low. This suggests the metastatic tumors can
be distinguished from the primary tumors of the same
type by using the proposed relative confidence criterion.
NCI60 data
There were no independent test (validation) samples in
the NCI60 dataset. Consequently, ten-fold cross valida-
tion was conducted as in Statnikov et al (2005) [10]. The
results are summarized in Figure 5. In most scenarios, the
prediction accuracy ranged from 66.7% to 73.3%. The
improvement due to the use of the PST algorithm was not
as significant as with the GCM data. A modest improve-
ment was observed when the number of used genes was
relative small (200 - 300). One explanation is that,
because some tumor types had a very limited number of
samples (4-5 samples) available for training the classifiers,
Figure 3 Prediction accuracy in the cross validation for GCM dataset.
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holding out one sample from the training set as is
required for the implementation of PST sharpened sam-
ple shortage and weakened the trained classifiers. Never-
theless, the prediction accuracy obtained was comparable
to the best reported results using this dataset. According
to Statnikov et al. (2005) [10], SVM-based methods per-
formed much better than k-NN, PNN (probabilistic neu-
ral network) and other non-SVM methods with an
accuracy ranging from 47.4% to 75.0%. Furthermore, it
was evident from our study that breast cancer (BR) sam-
ples were unpredictable. This result is consistent with
Ross et al (2000), in which the BR samples could not be
clustered together [19]. The reason could be that the BR
samples contained estrogen positive (ER+) and estrogen
negative (ER-) subtypes [19].
Conclusions
In cancer type predictions, multi-category problems have
proven to be more challenging than binary cases, not only
in the classification accuracy but also in the assessment of
uncertainty. In this paper, a jackknife-like classification
method, called paired-samples test algorithm (PST), was
proposed and applied to two bench datasets of multiple
tumor types [11,20]. The results showed that the pro-
posed method has improved the prediction accuracy of
test samples in the GCM dataset, especially when t-statis-
tics were used for primary feature selection. For the
NCI60 dataset, improvement was observed only when
the number of used genes was relative small. These
improvements made the binary regression algorithm
more robust to gene selection and the number of genes
used.
The core idea of the proposed method is to repeatedly
test a certain known tumor type with a blind test sample
while withholding an associated training sample; in this
way, not only can the prediction be made but also the rel-
ative confidence R(T) of the prediction can be accessed by
measuring the difference between the prediction proba-
bility of the test sample and the corresponding value of
the withheld training sample. R(T) provided insight into
the sources of the uncertainty in the statistical classifica-
tion by revealing the loss in confidence due to the utiliza-
tion of weak classifiers or heterogeneity in a given tumor
type. It is possible to combine the measurement F(T) and
R(T) to make a better score for type determination. Our
continuous work will consider this possibility in regards
to penalizing a negative R(T) value.
Figure 4 Prediction confidence and relative confidence for the 45 correctly classified samples using fold change-based gene selection and 
paired-samples test algorithm in the independent test for GCM dataset. The 6 samples to right end were metastatic tumors.
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Methods
Paired-samples test algorithm
Background
When the distribution of the data is complex and/or the
training set is small compared to the feature dimension,
the combined decision of an ensemble of multiple classi-
fiers can be used to improve the performance of a single
classification rule [13]. The bagging procedure is one
such technique widely used to establish multiple classifi-
ers [21]. It consists of training a set of classifiers, each
being based on a bootstrap replicate of the training set,
and aggregating them according to relative credits or
weights. In the process of training classifiers for tumor
prediction using microarray data, a feature selection step
is usually performed in order to decrease noise. There-
fore, the bagging technique could improve the robustness
for the prediction mainly due to the fact that each classi-
fier has its specific training set and group of selected fea-
tures. However, for multi-category problems, the
application of bagging techniques is subject to some limi-
tations due to the partition of the training set as
described in the following paragraph.
Assume the original training set includes 10 tumor
types labeled with letters from A to J, and each type has 8
samples. In establishing an OVR classifier for separating
type A from others, the training data will be divided into
two groups, one containing the A samples (8 samples)
and another containing the remaining 72 samples (B to J).
Although the training set is not small in size, it is
extremely asymmetric. Theoretically, in a bootstrap repli-
cate of the same size, the probability of a sample being
included is  [21]. Thus, the number of A sam-
ples in some replicates may be very small, leading to an
inaccurate classifier. Furthermore, a valid bagging tech-
nique requires a great deal of replicates. Consequently,
combining a bagging technique with computationally
intensive classification algorithms and gene extraction
methods may become impractical due to high computa-
tional cost. In order to overcome these shortcomings, we
10 6 3 1 −≈ e .
Figure 5 Prediction accuracy in the cross validation for NCI60 dataset.
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propose a paired-samples testing algorithm, a parsimoni-
ous jackknife-like method.
Paired-samples test algorithm (PST)
The algorithm is based on the concept of jackknifing. For
every tumor type, multiple classifiers are established. The
size of the classifier ensemble is equal to the number of
the training samples of the tumor type in the original
data. Each classifier is trained on a data set with one sam-
ple of the tumor type withheld. Using the same classifier,
the withheld sample is "predicted" together with the test
samples (for description convenience and without loss of
generality, we assume there is only one sample in the test
set). The probabilities that the two samples belong to the
same tumor type are computed and a relative value is cal-
culated as the difference of the two probabilities. By
aggregating the results from the multiple classifiers, the
probability that the test sample belongs to the tumor type
and its relative confidence are obtained. Similarly, the
same quantities (probability and relative confidence) are
calculated for the remaining other tumor types in the test
sample. Finally, the maximum confidence rule is used to
determine the tumor type for the test sample and to
report the confidence and relative confidence for the pre-
diction. Figure 6 shows the flow process of the algorithm.
The mathematical process is illustrated in Figure 7. The
data set contained three tumor types labeled A, B and C
with na, nb and nc training samples, respectively. T is the
test sample for which the tumor type is to be determined,
and CLA, CLB and CLC represent the three classifier
ensembles for tumor type A, B and C, respectively. p(T T
A|CLA- i) represents the probability that test sample T
belongs to tumor class A under classifier CLA-i,, where
the subscript i indicates that sample Ai was removed from
the training set. All other probabilities are defined in the
same way.   and   represent the confidences
that T belongs to tumor type A, B and C, respectively, and
 and   are the relative confidences. P(T) = λ
indicates that sample T has been classified as tumor type
λ (λ = A, B or C), and F(T) and R(T) are the prediction
confidence and relative confidence, respectively.
Prediction uncertainty
Uncertainty is usually evaluated through its reverse rela-
tionship with some confidence measurements [6,7,11].
However, a low prediction confidence for a given sample
may stem from the inadequacy of the classifiers used and/
or the sample itself. In this study, for a test example T, in
addition to the confidence measurement F(T) to be used
for class determination, the relative confidence R(T) was
calculated in order to provide insight into the sources of
uncertainty in the statistical classification. It was defined
as the aggregated difference between the estimates (from
the series of sub-classifiers based on the training sets) of
the probability that the blind test sample T belongs to the
assigned tumor type, and the correspondent values for
the training samples that actually belong to the class
which are paired with T. As showed in Figure 1, R(T)
measures the similarity of a particular test sample that
has been assigned to a specific tumor type class relative to
samples known to be of the same tumor type. If R(T) does
not deviate much from zero, the sample could be consid-
ered as an "average" tumor of the assigned type. In this
case, even a low F(T) does not represent a severe problem
because the uncertainty is mainly due to potential limita-
tions of the used classifier. However, when R(T) deviates
substantially from zero in the negative direction, a small
to medium magnitude for F(T) could indicate that the
test sample is likely to be a member of an unknown sub-
type or variant that is absent or less represented in the
training set. A large positive R(T) will very likely indicate
a high heterogeneity between the training samples in the
tumor type in which the test sample was classified as
indicated in Figure 8.
Binary classification algorithm
A binary classification algorithm was nested in PST and
was performed to establish the series sub-classifiers and
calculate the classification probabilities, such as CLA-  i
and p(T T A|CLA- i) as indicated in Figure 7. Prior to each
implementation, the genes were selected with the infor-
mation of the involved training samples and by using the
methods described in section 2.3.
In this algorithm, the relationship between the binary
response,  Y  = (Y1,  Y2, ... Yn), and the gene expression
matrix, X = (X1, X2, .. Xn), was modeled via a continuous
and unobserved latent random variable (liability) λ = (λ1,
λ2, ..., λn) such that
FF T
A
T
B () () , FT
C ()
RR T
A
T
B () () , RT
C ()
Figure 6 Flow chart of paired-sample test algorithm.
OVR scheme: assume one cancer type as the positive class and 
the remain type as negative class alternatively
Based on each sub-classifier, calculate the probability and relative 
confidence that the blind test sample belongs to the positive class
Determine the cancer type of the blind test sample from the results of all 
the OVR partitions by using a maximum confidence rule
For each OVR partition, establish multiple sub-classifiers based 
on the perturbed datasets with one training sample held-out alternatively
Aggregate the confidence measures from the multiple sub-classifiers
Report the confidence and relative confidence for the prediction
for the blind test sample. Zhang et al. BMC Genomics 2010, 11:273
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and
where β was a vector containing model parameters.
The link function of the linear predictor   with the
binary response Yi was structured via a probit model
[6,22,23]. That is
where Φ (·) was the standard normal cumulative distri-
bution function.
Due to the fact that the number of genes was larger
than the number of samples, a dimension reduction tech-
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Figure 7 Illustration of paired-sample test algorithm.
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CLA-I represents  a classifier trained without sample Ai in the training set. CLB-j and CLC-k are defined in the same way.
Figure 8 Illustration of classification in the presence of a hetero-
geneous cancer type. "B" indicates samples in training set and "T" is a 
test sample. The latter is closer to the center of the class than some 
training samples leading to a positive relative confidence.
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nique called singular value decomposition (SVD)  was
performed on the gene expression matrix X  [6]. The
resulting model is equivalent to the one in equation (3)
but with "eigen-genes" as the exploratory factors [24].The
reduced regression model had the dimension of its
parameter vector γ equal to the number of samples in the
training set. The parameter vector, γ was estimated using
Gibbs sampling, and β  in equations (2) and (3) was
obtained as a by linear transformation of the estimates of
the reduced model [6,7]. The technical details of the
implementation of SVD and Gibbs sampling can be found
in West et al (2001) and Zhang et al (2006) [6,7]. We also
tried using ICA (Independent Component Analysis) to
replace SVD for dimension reduction [25], however no
positive improvement in the prediction performance was
achieved (results not shown).
Feature selection
Feature selection steps were required for cancer classifi-
cation with gene expression profiling. In this study, four
gene ranking methods were combined with PST. All the
calculations were based on log2 transformed gene expres-
sion data.
Fold change (FC)
It is calculated with the formula FC = |Mo - Mr|. In OVR
setup, Mo represents the mean of the training samples in a
single tumor type to be separated from the others, and Mr
represents the mean of the training samples in all other
cancer types.
t-statistic
It is defined as
where Sp is the pooled standard deviation, No and Nr are
the numbers of the training samples in the two groups,
respectively, and Mo  and  Mr  are the same as defined
above. Gene ranking is based on the absolute values.
Penalized t-statistic
It penalizes genes with small Sp by adding a positive quan-
tity, a, to the denominator of the t-statistic, represented
by the formula:
In this study, δ was set to a value equal to the ninetieth
percentile of the distribution of the standard deviations of
Sp for all genes in the array [26].
Kruskal Wallis non-parameter test (NP-ANOWA)
The statistic in this test was defined as
where Ri is the sum of ranks in group i, ni is the number
of observations in the ith group, and n is the sample size.
There are e distinct values, with v1 equal to the smallest,
v2 equal to the next smallest and so on. In OVR setup, the
test reduces to the two-sided Mann-Whitney's Test. For
gene ranking, only the statistic W is required.
Data
The proposed method was applied to two well-known
and challenging datasets that have been analyzed previ-
ously by several groups.
GCM dataset
It consisted of 144 and 54 training and testing samples,
respectively, representing 14 tumor types [11]. These
tumor types included BR (breast adenocarcinoma), PR
(prostate adenocarcinoma), LU (lung adenocarcinoma),
CO (colorectal adenocarcinoma), LY (lymphoma), BL
(bladder transitional cell carcinoma), ML (melanoma),
UT (uterine adenocarcinoma), LE (leukemia), RE (renal
cell carcinoma), PA (pancreatic adenocarcinoma), OV
(ovarian adenocarcinoma), ME (pleural mesothelioma)
and CNS (central nervous system). All samples were pri-
mary tumors with the exception of eight metastatic
tumors in the test set. Expression data was generated
using Affymetrix high-density oligonucleutide microar-
rays containing 16,043 known human genes or expressed
sequence tags (EST). Cancer types LY, CNS and LE have
more training samples in the original dataset. Based on
literature [11,15] and our primary analysis of the data,
samples for these three types were consistently predicted
with very high accuracy (95-100%). In the current study,
in order to remove the concern that the high accuracy
was related to the larger training sets, only 8 training
samples for each of the tumor types were used for the
prediction of test samples.
NCI60
The 60 cell lines were derived from tumors: 8 breast, 5
central nervous system, 7 colon, 6 leukemia, 8 melanoma,
9 non-small-cell-lung-carcinoma (NSCLC), 6 ovarian, 2
prostate, and 8 renal [20]. Because of their small class
size, the two prostate cell lines were excluded from our
analysis. Expression data was generated using Affymetrix
high-density oligonucleutide microarrays containing
6,817 human genes [20].
For both datasets, the expression intensities for each
gene were calculated using Affymetrix GENECHIP anal-
ysis software. In the current study, some preprocessing
t
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was conducted on the data provided in literature [11,20].
It consisted of threshold treatment of the expression
intensities with 20 for GCM data (1 for NCI60 data) and
16,000 as the lower and upper limit, respectively, after
which the log2 transformation was applied. Further, genes
with the highest transformed intensity smaller than two
times the minimum expression across all samples of each
dataset were deleted.
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